These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30768836)

  • 21. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study.
    Wadden TA; Hollander P; Klein S; Niswender K; Woo V; Hale PM; Aronne L;
    Int J Obes (Lond); 2013 Nov; 37(11):1443-51. PubMed ID: 23812094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacotherapy for obesity].
    Bruun JM
    Ugeskr Laeger; 2016 Oct; 178(44):. PubMed ID: 27808050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Liraglutide and Behavioral Weight Loss on Food Cravings, Eating Behaviors, and Eating Disorder Psychopathology.
    Chao AM; Wadden TA; Walsh OA; Gruber KA; Alamuddin N; Berkowitz RI; Tronieri JS
    Obesity (Silver Spring); 2019 Dec; 27(12):2005-2010. PubMed ID: 31746553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiobesity drugs before and after bariatric surgery - how to make the best use of them.
    Šrámková P; Fried M
    Cas Lek Cesk; 2022; 161(3-4):107-113. PubMed ID: 36100447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exposure-response analyses of liraglutide 3.0 mg for weight management.
    Wilding JP; Overgaard RV; Jacobsen LV; Jensen CB; le Roux CW
    Diabetes Obes Metab; 2016 May; 18(5):491-9. PubMed ID: 26833744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The limits and challenges of antiobesity pharmacotherapy.
    Gadde KM; Atkins KD
    Expert Opin Pharmacother; 2020 Aug; 21(11):1319-1328. PubMed ID: 32292094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liraglutide: a review of its use in the management of obesity.
    Scott LJ
    Drugs; 2015 May; 75(8):899-910. PubMed ID: 25985864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial.
    Khoo J; Hsiang J; Taneja R; Law NM; Ang TL
    Diabetes Obes Metab; 2017 Dec; 19(12):1814-1817. PubMed ID: 28503750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.
    Astrup A; Rössner S; Van Gaal L; Rissanen A; Niskanen L; Al Hakim M; Madsen J; Rasmussen MF; Lean ME;
    Lancet; 2009 Nov; 374(9701):1606-16. PubMed ID: 19853906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of adjuvant weight loss medication after bariatric surgery.
    Nor Hanipah Z; Nasr EC; Bucak E; Schauer PR; Aminian A; Brethauer SA; Cetin D
    Surg Obes Relat Dis; 2018 Jan; 14(1):93-98. PubMed ID: 29287757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variability in GLP-1 receptor is associated with inter-individual differences in weight lowering potential of liraglutide in obese women with PCOS: a pilot study.
    Jensterle M; Pirš B; Goričar K; Dolžan V; Janež A
    Eur J Clin Pharmacol; 2015 Jul; 71(7):817-24. PubMed ID: 25991051
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends and Outcomes Associated With Bariatric Surgery and Pharmacotherapies With Weight Loss Effects Among Patients With Heart Failure and Obesity.
    Mentias A; Desai MY; Aminian A; Patel KV; Keshvani N; Verma S; Cho L; Jacob M; Alvarez P; Lincoff AM; Van Spall HGC; Lam CSP; Butler J; Nissen SE; Pandey A
    Circ Heart Fail; 2024 Feb; 17(2):e010453. PubMed ID: 38275114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.
    Jensterle M; Kravos NA; Pfeifer M; Kocjan T; Janez A
    Hormones (Athens); 2015; 14(1):81-90. PubMed ID: 25885106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvements in health-related quality of life over 3 years with liraglutide 3.0 mg compared with placebo in participants with overweight or obesity.
    Kolotkin RL; Gabriel Smolarz B; Meincke HH; Fujioka K
    Clin Obes; 2018 Feb; 8(1):1-10. PubMed ID: 29045079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.
    Davies MJ; Bergenstal R; Bode B; Kushner RF; Lewin A; Skjøth TV; Andreasen AH; Jensen CB; DeFronzo RA;
    JAMA; 2015 Aug; 314(7):687-99. PubMed ID: 26284720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Comparison of New Pharmacological Agents for the Treatment of Obesity.
    Nuffer W; Trujillo JM; Megyeri J
    Ann Pharmacother; 2016 May; 50(5):376-88. PubMed ID: 26887340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Prevented Weight Regain in Obese Women with Polycystic Ovary Syndrome Previously Treated with Liraglutide: A Pilot Randomized Study.
    Ferjan S; Janez A; Jensterle M
    Metab Syndr Relat Disord; 2017 Dec; 15(10):515-520. PubMed ID: 29064743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of bariatric surgery and weight loss medications in adults with type 1 diabetes in the T1D Exchange Clinic Registry.
    Vendrame F; Calhoun P; Bocchino LE; Pratley RE; Casu A
    J Diabetes Complications; 2021 Jun; 35(6):107884. PubMed ID: 33610436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liraglutide for weight loss in obese people.
    Thum T; Anker SD
    Lancet; 2010 Feb; 375(9714):551-2; author reply 552-3. PubMed ID: 20159285
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.